Chushin Venture Capital
VC Fund
Kyoto, Japan
Chushin Venture Capital is a venture capital fund established by Kyoto Chuo Shinkin Bank.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 0%
- Fund size:
- $2.7M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Chushin Venture Capital invests in
Stages Chushin Venture Capital invests in
Countries Chushin Venture Capital invests in
Round sizes
Round size
- Seed
- $1.5M–$2M
- Series A
- $955k–$8.1M
- Series B
- $1.5M–$15M
Investment Focus
Industry
- Biotechnology 5 (26%)
- Manufacturing 4 (21%)
- Medical 3 (16%)
- Health Care 3 (16%)
- Pharmaceutical 3 (16%)
Stage
- Series A 6 (32%)
- Seed 3 (16%)
- Series B 3 (16%)
- Series C 3 (16%)
- Venture - Series Unknown 3 (16%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Spectronics is a development of new technologies and new applications to bring about innovation, focusing on the future of laser technology. | $3.3M / Series F / Oct 01, 2026 | ||
| AOI Biosciences is a biotechnology company that creates testing and drug discovery businesses. | $3.2M / Venture - Series Unknown / Sep 14, 2026 | ||
| Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia. Toregem BioPharma is headquartered in Kyoto, Japan. | $5.3M / Series C / May 19, 2026 | ||
| Nexta manufactures site, issues such as analog management, personalization of operations & labor shortages are becoming more serious. | $5.1M / Series B / Nov 26, 2025 | ||
| OOYOO is a Tech venture, which researches and development of gas separation membranes for carbon dioxide, hydrogen, etc. | $2M / Seed / Oct 15, 2025 | ||
| Cizucu is a stock photo community that helps creators and brands to create photos. | Seed / Jun 25, 2025 | ||
| HOLO BIO is a research and technology firm that employs biological breeding techniques to address the food challenges faced by humanity. | $1.5M / Seed / Jan 25, 2025 | ||
| MiCAN Technologies medical and nursing Care company we will provide the enabling tools to eliminate Malaria and other infectious diseases by the use of pluripotent stem cell. MiCAN Technologies through the provision of “blood cell-like cell products” produced using regenerative medicine technology,They will help you research malaria and otherinfectious and immune system diseases. | $1.6M / Venture - Series Unknown / Jan 24, 2025 | ||
| Regional Fish provides seed, seedlings, aquaculture methods and fisheries services. | $19.1M / Series C / Dec 26, 2024 | ||
| RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a type of radiation therapy that utilizes the nuclear reaction between thermal neutrons and boron-10 (¹⁰B) to destroy cancer cells by releasing alpha particles and lithium nuclei. | $954.7K / Series A / Dec 25, 2024 | ||
| See all 19 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Chushin Venture Capital invest in?
Chushin Venture Capital invests primarily in Biotechnology, Manufacturing and Medical startups, most often at Series A and Seed stage. Most of the 19 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Chushin Venture Capital invest in?
Chushin Venture Capital typically joins rounds of $1.5M–$2M at Seed, $955k–$8.1M at Series A and $1.5M–$15M at Series B. These are whole funding-round sizes, not Chushin Venture Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Chushin Venture Capital took part in.
When did Chushin Venture Capital last invest?
The most recent investment recorded for Chushin Venture Capital closed in Oct 2026. Shizune tracks 19 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
